Effectiveness and cost-effectiveness of a patient-initiated botulinum toxin treatment model for blepharospasm and hemifacial spasm compared to standard care: study protocol for a randomised controlled trial

被引:0
作者
Sadie Wickwar
Hayley McBain
Stanton P. Newman
Shashivadan P. Hirani
Catherine Hurt
Nicola Dunlop
Chris Flood
Daniel G. Ezra
机构
[1] City University London,Centre for Health Services Research, School of Health Sciences
[2] Moorfields Eye Hospital,Community Health Newham
[3] East London Foundation Trust,undefined
来源
Trials | / 17卷
关键词
Blepharospasm; Hemifacial spasm; Botulinum toxin; Patient-led care; Quality of life; Illness perceptions; Randomised controlled trial; Protocol; Acceptability;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 116 条
[1]  
Kraft SP(1988)Cranial dystonia, blepharospasm and hemifacial spasm: clinical features and treatment, including the use of botulinum toxin CMAJ: Canadian Medical Association Journal 139 837-6
[2]  
Lang AE(2002)The impact of blepharospasm and cervical dystonia on health-related quality of life and depression J Neurol 249 842-70
[3]  
Müller J(2005)Health-related quality of life in blepharospasm or hemifacial spasm Acta Neurologica Scandinavica 111 64-43
[4]  
Kemmler G(2013)The focal dystonias: current views and challenges for future research Movement Disorders 28 926-73
[5]  
Wissel J(2012)Efficacy and safety of long-term botulinum toxin treatment in craniocervical dystonia: a systematic review Neurotoxicity research 22 265-23
[6]  
Schneider A(2013)Patient initiated clinics for patients with chronic or recurrent conditions managed in secondary care: a systematic review of patient reported outcomes and patient and clinician satisfaction BMC health services research 13 501-13
[7]  
Voller B(2013)Mixed methods in biomedical and health services research Circulation: Cardiovascular Quality and Outcomes 6 119-80
[8]  
Grossmann J(1987)Botulinum A toxin for cranial-cervical dystonia: a double-blind, placebo-controlled study Neurology 37 616-8
[9]  
Reimer J(2009)Relationship between various clinical outcome assessments in patients with blepharospasm Movement Disorders 24 407-12
[10]  
Gilg K(2012)Botulinum toxin in hemifacial spasm: the challenge to assess the effect of treatment Journal of neural transmission 119 963-7